Iteos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

iTeos Therapeutics

08/08/2023 13:53

* Iteos Therapeutics Inc  ITOS.OQ  reported a quarterly
adjusted
loss of 96 cents​​ per share for the quarter ended in June. The
mean expectation of five analysts for the quarter was for a loss
of $1.03 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Iteos Therapeutics Inc's reported EPS for the quarter was
a loss
of 96 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Iteos Therapeutics Inc shares had fallen by 6.0% this
quarter and lost 36.3% so far this year.
    * The company reported a quarterly loss of $34.3 million.
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $41.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 8 at 12:53 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -1.03          -0.96          Beat
 Mar. 31 2023      -0.99          -0.44          Beat
 Dec. 31 2022      0.33                          
 Sep. 30 2022      0.10           0.03           Missed